LIN YANG
LIN YANG
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer | Gastric Cancer Adenocarcinoma Metastatic | Recruiting | Phase 2 | 2024-12-02 | NCT06711471 |